EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients

Maaike R Schagen iD, Teun B Petersen, Boris C A Seijkens, Jasper J Brugts, Kadir Caliskan, Alina A Constantinescu, Brenda C M de Winter, Isabella Kardys, Dennis A Hesselink iD, Olivier Manintveld

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Maaike R Schagen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Tacrolimus, Immunosuppressive Agents, Heart Transplantation, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Heart transplantation (HT) is frequently complicated by chronic kidney disease, of which tacrolimus‐related nephrotoxicity is an important cause. In kidney and liver transplant recipients, fast tacrolimus metabolism (defined as a low concentration‐to‐dose [ C 0 / D ] ratio), negatively affects kidney function. Here, the association between the C 0 / D ratio and kidney function in HT recipients was investigated.

Methods

This was a retrospective study including 209 HT recipients who received an immediate‐release tacrolimus formulation. The C 0 / D ratio and kidney function (estimated glomerular filtration rate [eGFR]) were assessed at 3, 6, 12, 36 and 60 months post‐HT. Patients were categorized as fast, intermediate and slow metabolisers, depending on their individual median C 0 / D ratio as calculated over the follow‐up period. A linear mixed‐effects model analysis was performed, in which the time‐varying eGFR was the dependent variable.

Results

The distribution of the individual median C 0 / D ratios ranged from 0.41 to 8.9 ng/mL/mg. At baseline, patients' kidney function was comparable. In the multivariable linear mixed‐effects model, fast metabolisers ( C 0 / D ratio ≤1.53) had a significantly lower eGFR compared to slow metabolisers ( C 0 / D ratio >2.27) (−6.8 mL/min/1.73 m 2 , 95% CI −11.2, −2.4, p = 0.002). This association was confirmed when utilizing the individual median C 0 / D ratio as a continuous variable: for each 1 unit increase in the C 0 / D ratio there was a 2.8 mL/min/1.73 m 2 (95% CI 1.0, 4.5) increase in eGFR ( P = 0.002).

Conclusion

Fast tacrolimus metabolism is significantly associated with worse kidney function in HT recipients in the first 5 years post‐HT when compared to recipients with intermediate and slow tacrolimus metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusImmunosuppressive AgentsHeart TransplantationRenal Insufficiency, ChronicHumansMaleFemaleRetrospective StudiesMiddle AgedGlomerular Filtration RateAdultAgedKidneyGraft RejectionDose-Response Relationship, DrugFollow-Up Studies

Stichwörter der Autor:innen

chronic kidney diseasedrug metabolismimmunosuppressiontransplantation

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

ORCID-Profile: Maaike R Schagen, Dennis A Hesselink

Zitieren

APA

Schagen, M. R., Petersen, T. B., Seijkens, B. C. A., Brugts, J. J., Caliskan, K., Constantinescu, A. A., de Winter, B. C. M., Kardys, I., Hesselink, D. A., & Manintveld, O. (2025). The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70041

Vancouver

Schagen MR, Petersen TB, Seijkens BCA, Brugts JJ, Caliskan K, Constantinescu AA, et al. The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70041

BibTeX
@article{Schagen2025,
  author = {Schagen, Maaike R and Petersen, Teun B and Seijkens, Boris C A and Brugts, Jasper J and Caliskan, Kadir and Constantinescu, Alina A and de Winter, Brenda C M and Kardys, Isabella and Hesselink, Dennis A and Manintveld, Olivier},
  title = {The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70041}
}
Kostenlos starten →